Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06877520

Early Feasibility of 'Pivot Extend' for Tricuspid Regurgitation Treatment

Early Feasibility Study (EFS) of the 'Pivot Extend' in Treatment for Tricuspid Regurgitation (SPACER Study)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
7 (estimated)
Sponsor
Tau-MEDICAL Co., Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This clinical trial aims to evaluate the safety and demonstrate the efficacy of treatment to improve tricuspid regurgitation (TR) symptoms in patients with severe and clinically symptomatic TR through long-term implantation of an investigational medical device. 1. Determine the safety of long-term implantation of the investigational medical device "Pivot Extend" by monitoring for MACEs associated with the investigational medical device or procedure that may occur with long-term associated with the investigational medical device or procedure that may occur with long-term implantation. 2. Device success, procedural success, and clinical outcomes of long-term implantation of the investigational medical device "Pivot Extend" will be monitored.

Conditions

Interventions

TypeNameDescription
DEVICEPivot Extend Tricuspid Regurgitation Spacer DeviceThe Pivot Extend Tricuspid Regurgitation Spacer Device is an investigational implant designed to reduce tricuspid regurgitation (TR) by occupying the regurgitant orifice and improving leaflet coaptation. The device is implanted via a transcatheter procedure under imaging guidance. Following implantation, participants will undergo post-procedural monitoring for at least 24 hours to ensure safety and device stability. The device is intended for long-term placement, with scheduled follow-up assessments at designated intervals over a 12-month period to evaluate its safety and efficacy. Device removal may be performed if adverse events occur or if deemed necessary by the investigator.

Timeline

Start date
2025-05-01
Primary completion
2026-05-01
Completion
2026-12-01
First posted
2025-03-14
Last updated
2025-04-11

Locations

3 sites across 1 country: Georgia

Source: ClinicalTrials.gov record NCT06877520. Inclusion in this directory is not an endorsement.